AzTrials
AzTrials

Physiologic Venous DilationNCT07808411

Prospective Repeated-Measures Study of Popliteal Vein Diameter During the First 48 Hours After Commercial Air Travel to Bogota for a Plastic Surgery Intervention

An observational study of Physiologic Venous Dilation and Air Travel, run by Research Inc at 1 site in Colombia.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This prospective repeated-measures study will evaluate how long popliteal vein dilation persists after international commercial air travel to Bogota. Adult medical travelers will undergo standardized bilateral popliteal vein ultrasound within 24 hours before departure, within 2 hours after arrival, and at 24 and 48… Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Physiologic Venous Dilation, Air Travel
What is being tested?
Commercial Air Travel Exposure and Standardized Bilateral Popliteal Vein Duplex Ultrasound
How many people
100 participants
Where
1 siteColombia
Study dates
12 Jan 2024to 1 Dec 2026
How long will I take part?
1 Week
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult international medical travelers completing a commercial flight of at least 4 hours to Bogota and undergoing all ultrasound measurements before surgery.

Who may be able to join

  • Age 18 to 65 years.
  • International commercial flight to Bogota with total airborne time of at least 4 hours.
  • Preflight baseline ultrasound obtained within 24 hours before departure using the standardized protocol.
  • Arrival ultrasound completed within 2 hours after reaching the study site and before surgery or intravenous fluid therapy.
  • Availability for 24-hour and 48-hour examinations.
  • Written informed consent.

Who cannot join

  • Known current deep venous thrombosis or pulmonary embolism.
  • Therapeutic anticoagulation at enrollment.
  • Major lower-extremity venous surgery, active leg infection, or condition preventing popliteal ultrasound.
  • Surgery, prolonged immobilization, or substantial intravenous fluid administration before completion of the 48-hour measurement.
  • Pregnancy.
  • Nondiagnostic baseline examination or inability to reproduce the landmark.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Hugo Aguilar, MD, Plastic surgeon contact

+57 301 6918526

havplasticacademy@gmail.com

Colombia1 site, 1 recruiting
  • Clinica INO

    Bogotá

    hugo Aguilar, MD, Plastic surgeon, +57 3016918526, havplasticacademy@gmail.com

    Recruiting

Other trials in Colombia

About this study

This prospective repeated-measures study will evaluate how long popliteal vein dilation persists after international commercial air travel to Bogota. Adult medical travelers will undergo standardized bilateral popliteal vein ultrasound within 24 hours before departure, within 2 hours after arrival, and at 24 and 48 hours after arrival, all before surgery. The primary outcome is change in mean bilateral popliteal vein diameter over time.

Read the detailed description

Eligible international travelers will complete a standardized preflight ultrasound and three postarrival examinations before surgery or intravenous fluid therapy. Each scan will be performed after a fixed resting period using the same popliteal landmark, minimal transducer pressure, and triplicate bilateral measurements. Flight duration, class, seat characteristics, movement, fluid intake, compression stocking use, and venous risk factors will be recorded. Mixed-effects analysis will estimate the postflight diameter and cross-sectional-area trajectory and the proportion returning to within 10% of baseline by 48 hours.

Being tested
Commercial Air Travel Exposure, Standardized Bilateral Popliteal Vein Duplex Ultrasound
Keywords
Popliteal Vein, Air Travel, Medical Tourism, Venous Diameter, Duplex Ultrasound, Long-Haul Flight

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Commercial Air Travel ExposureOther

    Participants complete a commercial flight of at least 4 hours to Bogota. Flight duration, connections, cabin class, seat characteristics, movement, fluid intake, alcohol, sedatives, and compression stocking use will be recorded. Linked arm/group(s): Postflight Repeated-Measures Cohort.

  • Standardized Bilateral Popliteal Vein Duplex UltrasoundDiagnostic test

    After at least 10 minutes of supine rest, the popliteal vein will be imaged at a fixed landmark with minimal probe pressure. Anteroposterior and transverse diameters, cross-sectional area, compressibility, and flow will be recorded in both legs, with three repeated measurements averaged. Linked arm/group(s): Postflight Repeated-Measures Cohort.

Study groups in NCT07808411
Study groupRoleWhat they receive
Postflight Repeated-Measures CohortAll participants undergo standardized preflight and postarrival bilateral popliteal vein ultrasound without assignment to a travel intervention.
Receives: Other: Commercial Air Travel Exposure; Diagnostic Test: Standardized Bilateral Popliteal Vein Duplex Ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Mean Bilateral Popliteal Vein Diameter

    At each visit, the mean of three anteroposterior diameter measurements in each leg will be calculated, followed by the mean of both legs. Change from the participant's preflight value will be reported in millimeters and as percent change.

    Measured: Within 24 hours before departure; within 2 hours after arrival at the study site; 24 +/- 2 hours after arrival; and 48 +/- 2 hours after arrival. 1 week

Secondary outcomes (2)
  1. Return of Popliteal Vein Diameter to Baseline

    Proportion of participants whose mean bilateral diameter is within plus or minus 10% of their preflight value.

    Measured: 24 +/- 2 hours and 48 +/- 2 hours after arrival. 1 week

  2. Incidental Venous Thrombosis or Abnormal Compressibility

    Number and proportion of participants with a new noncompressible venous segment or other finding requiring diagnostic clinical evaluation. This research protocol is not designed as a definitive thrombosis screening examination unless the final duplex protocol is expanded.

    Measured: From preflight baseline through 48 hours after arrival. 1week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Sep 2026
  2. Study start12 Jan 2024
  3. Primary completion1 Sep 2026
  4. Study completion1 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
Target duration
1 Week
IDs, dates and publications
ClinicalTrials.gov ID
NCT07808411
Sponsor's protocol ID
015
Status last verified
Sep 2026
First submitted
2 Sep 2026
Last updated
8 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: not contempled in the patient informed consent

Publications

  • Hoyos AE, Ramirez B, Benavides J, Perez Pachon ME, Varela A. Aeromedical Considerations for Patient Safety in Aesthetic Medical Tourism. Aerosp Med Hum Perform. 2024 Oct;95(10):765-770. doi: 10.3357/AMHP.6432.2024.

    PubMed 39431700
  • Ramirez B, Aguilar H, Stanford N, Paez Z, Menendez JP, Pachon J, Osorio E, Varela A. Aesthetic Surgical Tourism: Physiological Changes During Flight That May Affect Patient Safety and Outcomes. Plast Reconstr Surg Glob Open. 2026 May 8;14(5):e7568. doi: 10.1097/GOX.0000000000007568. eCollection 2026 May.

    PubMed 42110381

Questions about this trial

What is this clinical trial studying?

An observational study of Physiologic Venous Dilation and Air Travel, run by Research Inc at 1 site in Colombia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 8 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Colombia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Hugo Aguilar, MD, Plastic surgeon (+57 301 6918526, havplasticacademy@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Mean Bilateral Popliteal Vein Diameter (time frame: Within 24 hours before departure; within 2 hours after arrival at the study site; 24 +/- 2 hours after arrival; and 48 +/- 2 hours after arrival. 1 week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07808411, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in